Astraveus Astraveus SAS has inked a strategic partnership with NecstGen to evaluate Lakhesys Benchtop Cell Factory for CAR-T therapy manufacturing. Meanwhile, German researchers present a solution to the design of hypoimmunogenic CAR-T cells.
ADVERTISEMENT
Astraveus SAS has inked a strategic partnership with NecstGen to evaluate Lakhesys Benchtop Cell Factory for CAR-T therapy manufacturing. Meanwhile, German researchers present a solution to the design of hypoimmunogenic CAR-T cells.